• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

neurodegenerative diseases

NeuroSense Therapeutics and NeuraLight Collaborate to Detect ALS Oculometric Biomarkers

by Syed Hamza Sohail 07/28/2022 Leave a Comment

NeuroSense Therapeutics and NeuraLight Collaborate to Detect ALS Oculometric Biomarkers

What You Should Know: - NeuroSense Therapeutics Ltd., a company developing treatments for severe neurodegenerative diseases, and NeuraLight, a company developing objective and sensitive biomarkers for neurological disorders, today announced a collaboration to advance the science of digital biomarkers in the detection and monitoring of neurological diseases including amyotrophic lateral sclerosis (ALS). - This agreement marks NeuraLight’s first clinical trial and comes on the heels of
Read More

When It Comes to Digital Health, Experience Is Everything

by Aniket Singh Rajput, Founder and CEO of Neuroglee 06/27/2022 Leave a Comment

When It Comes to Digital Health, Experience Is Everything

Thanks to COVID-19 and numerous other factors, the adoption of digital health technologies used by patients in the home has skyrocketed. Accenture reported in 2021, for example, that remote patient monitoring technology adoption tripled among patients. Whether it is streaming video telehealth appointments with a provider, a remote patient monitoring platform, or a prescribed digital therapeutic to manage a chronic condition, the emphasis must be on the patient and caregiver
Read More

Aetion and Cognito Team Up for Predictive Modeling in Alzheimer’s

by Jasmine Pennic 03/08/2022 Leave a Comment

Aetion and Cognito Team Up for Predictive Modeling in Alzheimer’s

What You Should Know: - Aetion, real-world evidence (RWE) tech and analytics provider, and Cognito Therapeutics, a pioneer in neuromodulation therapeutics for neurodegenerative diseases like Alzheimer’s, are partnering to develop an AI-driven predictive model to help payers and providers identify patients with rapidly progressing mild cognitive impairment (MCI) and Alzheimer’s who may benefit from earlier treatment.  Impact of MCI & Alzheimer’s Disease There are approximately 13.5
Read More

C. Light Launches AI-Driven Retinal Eye-Tracking; Predicts Neurological Health in 10 Seconds

by Jasmine Pennic 02/12/2020 Leave a Comment

C.Light Launches AI-Driven Retinal Eye-Tracking; Predicts Neurological Health in 10 Seconds

- C. Light Technologies launches the world’s first AI-driven retinal eye-tracking technology to assess neurological health in the blink of an eye. - The neurotech & AI company has the most sensitive tracker for eye motion on the cellular scale available today to predict neurological diseases in seconds. C. Light Technologies, a Berkeley, CA-based neurotech and AI company participating in UC Berkeley’s premier accelerator SkyDeck, is introducing the world’s first retinal
Read More

Philips Debuts AI-Driven Clinical Solution for Aiding Cognitive Assessment in the U.S.

by Fred Pennic 11/12/2019 Leave a Comment

Philips Debuts AI-Driven Clinical Solution for Aiding Cognitive Assessment in the U.S.

- Philips IntelliSpace Cognition provides U.S. healthcare professionals with a powerful aid for assessing cognitive impairments due to neurological conditions. - Philips has invested in collecting insights from both neurologists and neuropsychologists in order to design IntelliSpace Cognition in an iterative manner and ensure it fits into the majority of existing workflows. - IntelliSpace Cognition will initially be commercially available only in the U.S. Philips, a global leader in
Read More

Octave Bioscience Grabs $14M for Care Management Platform Focused on Neurodegenerative Diseases

by Fred Pennic 07/12/2018 Leave a Comment

Octave Bioscience Grabs $14M for Care Management Platform Focused on Neurodegenerative Diseases

Octave Bioscience lands $14M to bring expertise in chronic neurodegenerative markets and molecular Insights for improved care.Octave Bioscience, a Menlo Park, CA-based developer of a fully integrated care management platform delivering powerful insights for patients with neurodegenerative diseases, today announced it has raised $14 million in Series A funding. The round was led by BCBS Venture Partners with participation from Echo Health Ventures (a strategic collaboration of Cambia Health
Read More

Novartis to Acquire Gene Therapy Provider AveXis for $8.7B in Cash

by HITC Staff 04/09/2018 Leave a Comment

Novartis to Acquire Gene Therapy Provider AveXis for $8.7B in Cash

Novartis announced today that is has entered into an agreement to acquire  AveXis, Inc., a clinical stage gene therapy company for $8.7 billion in cash. AveXis lead product candidate, AVXS-101, has potential to be first-ever one-time gene replacement therapy for spinal muscular atrophy (SMA), a disease which results in early death or lifelong disability with considerable healthcare costs. It is estimated that one out of every 6,000-10,000 children born is affected by some form of SMA.The US Food
Read More

Northwell Health, GE Ventures Form $200M Alliance to Develop, Commercialize Solutions in Bioelectronic Medicine

by Jasmine Pennic 02/21/2017 Leave a Comment

Northwell Health, GE Ventures Form $200M Alliance to Develop, Commercialize Solutions in Bioelectronic Medicine

Today, GE Ventures announced a strategic partnership with Northwell Health’s Feinstein Institute for Medical Research providing up to $200 million in joint funding over seven years to support the opening of a new Center for Bioelectronic Medicine (CBEM), and advance diagnostic and therapeutic solutions for Alzheimer’s, cancer, diabetes, hypertension and more. The new alliance will greatly build upon groundbreaking work that started between the Feinstein Institute and a team of GE scientists
Read More

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Popular

Survey: Clinician Burnout Is A Public Health Crisis Demanding Urgent Action

17 Execs Share How Health IT Can Address Clinician Burnout, Staffing, & Capacity

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Northwell Health Extends Contract with Allscripts Sunrise Platform Through 2027

Northwell to Deploy Epic Enterprise EHR Platform Across System

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Pfizer Acquires Seagen for $43B to Tackle Cancer

Pfizer Acquires Seagen for $43B to Tackle Cancer

5 Key Trends Driving Purchasing Decisions in Healthcare IT

5 Key Trends Driving Purchasing Decisions in Healthcare IT

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Dr. Arti Masturzo

Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |